Clinical Trials Directory

Trials / Completed

CompletedNCT01992497

Cesarean Section Study

Effect,Tolerance and Safety of a Supplementation With a Probiotic in Healthy Newborn Term Infants Born by Cesarean Section Over a 12 Months Period Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
721 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
1 Minute – 24 Hours
Healthy volunteers
Accepted

Summary

Effect, tolerance and safety of a supplementation with a probiotic on the risk of gastrointestinal infections, on growth, and on gut microbiota in healthy newborn term infants born by Cesarean section. Exploratory comparison between a probiotic vs. placebo in the formula-fed and in the breastfed feeding groups.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic

Timeline

Start date
2013-12-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2013-11-25
Last updated
2020-04-24

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01992497. Inclusion in this directory is not an endorsement.

Cesarean Section Study (NCT01992497) · Clinical Trials Directory